NOVABAY PHARMACEUTICALS INC - COM (NBY)

CUSIP: 66987P102

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
2,046,079
Share change
-66,998
Total reported value
$2,371,330
Price per share
$1.17
Number of holders
21
Value change
-$97,782
Number of buys
9
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 66987P102?
CUSIP 66987P102 identifies NBY - NOVABAY PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVABAY PHARMACEUTICALS INC - COM (NBY) as of Q1 2014

As of 31 Mar 2014, NOVABAY PHARMACEUTICALS INC - COM (NBY) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,046,079 shares. The largest 10 holders included VANGUARD GROUP INC, GLENMEDE TRUST CO NA, GARRISON BRADFORD & ASSOCIATES INC, BRIDGEWAY CAPITAL MANAGEMENT INC, BlackRock Fund Advisors, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, DEUTSCHE BANK AG\, Orbitronix LP, GEODE CAPITAL MANAGEMENT, LLC, and Burns Wealth Management, Inc.. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.